Barinthus Biotherapeutics (BRNS)
undefined
undefined%
At close: undefined
0.91
0.00%
After-hours Dec 13, 2024, 03:55 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 802.00K 44.70M 268.00K 4.82M 6.87M
Cost of Revenue - - - - -0.55
Gross Profit 802.00K 44.70M 268.00K 4.82M 6.87M
Operating Income -83.91M -4.04M -45.22M -20.05M -25.77M
Interest Income 2.88M 3.10M 2.00K 267.06 40.37K
Pretax Income -76.52M 850.00K -51.14M -17.84M -22.79M
Net Income -73.35M 5.34M -50.87M -17.71M -20.82M
Selling & General & Admin 39.84M 6.39M 25.12M 10.48M 2.33M
Research & Development 44.87M 41.11M 16.37M 11.11M 29.97M
Other Expenses - 567.00K 332.00K 42.00K 0.00
Operating Expenses 84.72M 47.50M 41.49M 21.59M 32.30M
Interest Expense 28.00K 19.00K 2.67M 3.60M 133.30K
Selling & Marketing Expenses - - - - -
Cost & Expenses 84.72M 47.50M 41.49M 21.59M 32.64M
Income Tax -3.17M -4.47M -28.00K 95.00K -2.02M
Shares Outstanding (Basic) 38.39M 37.25M 37.19M 47.65K -
Shares Outstanding (Diluted) 38.39M 38.17M 37.19M 47.65K -
EPS (Basic) -1.91 0.14 -1.37 -371.62 -
EPS (Diluted) -1.91 0.14 -1.37 -371.62 -
EBITDA -74.81M 6.40M -47.86M -14.14M -22.31M
Depreciation & Amortization 5.45M 5.54M 601.93K 210.02K 346.86K